127 related articles for article (PubMed ID: 32393398)
1. Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay.
Sirisena N; Biswas K; Sullivan T; Stauffer S; Cleveland L; Southon E; Dissanayake VHW; Sharan SK
Breast Cancer Res; 2020 May; 22(1):43. PubMed ID: 32393398
[TBL] [Abstract][Full Text] [Related]
2. Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.
Biswas K; Das R; Eggington JM; Qiao H; North SL; Stauffer S; Burkett SS; Martin BK; Southon E; Sizemore SC; Pruss D; Bowles KR; Roa BB; Hunter N; Tessarollo L; Wenstrup RJ; Byrd RA; Sharan SK
Hum Mol Genet; 2012 Sep; 21(18):3993-4006. PubMed ID: 22678057
[TBL] [Abstract][Full Text] [Related]
3. Novel and reported pathogenic variants in exon 11 of BRCA2 gene in a cohort of Sri Lankan young breast cancer patients.
De Silva S; Tennekoon KH; Dissanayake A; De Silva K; Jayasekara L
Fam Cancer; 2017 Jul; 16(3):329-338. PubMed ID: 28039656
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and ES cell-based functional evaluation of BRCA2 variants identified in families with breast cancer.
Sullivan T; Thirthagiri E; Chong CE; Stauffer S; Reid S; Southon E; Hassan T; Ravichandran A; Wijaya E; Lim J; Taib NAM; Fadzli F; Yip CH; Hartman M; Li J; van Dam RM; North SL; Das R; Easton DF; Biswas K; Teo SH; Sharan SK; ;
Hum Mutat; 2021 Feb; 42(2):200-212. PubMed ID: 33314489
[TBL] [Abstract][Full Text] [Related]
5. Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs.
Biswas K; Mitrophanov AY; Sahu S; Sullivan T; Southon E; Nousome D; Reid S; Narula S; Smolen J; Sengupta T; Riedel-Topper M; Kapoor M; Babbar A; Stauffer S; Cleveland L; Tandon M; Malys T; Sharan SK
Cell Rep Methods; 2023 Nov; 3(11):100628. PubMed ID: 37922907
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches.
Guidugli L; Shimelis H; Masica DL; Pankratz VS; Lipton GB; Singh N; Hu C; Monteiro ANA; Lindor NM; Goldgar DE; Karchin R; Iversen ES; Couch FJ
Am J Hum Genet; 2018 Feb; 102(2):233-248. PubMed ID: 29394989
[TBL] [Abstract][Full Text] [Related]
7. Mis-splicing in breast cancer: identification of pathogenic BRCA2 variants by systematic minigene assays.
Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Goina E; Acedo A; Buratti E; Velasco EA
J Pathol; 2019 Aug; 248(4):409-420. PubMed ID: 30883759
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of human BRCA2 variants using a mouse embryonic stem cell-based assay.
Kuznetsov SG; Chang S; Sharan SK
Methods Mol Biol; 2010; 653():259-80. PubMed ID: 20721749
[TBL] [Abstract][Full Text] [Related]
9. Bypass of premature stop codons and generation of functional BRCA2 by exon skipping.
Stauffer S; Biswas K; Sharan SK
J Hum Genet; 2020 Sep; 65(9):805-809. PubMed ID: 32393813
[TBL] [Abstract][Full Text] [Related]
10. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
Santos C; Peixoto A; Rocha P; Pinto P; Bizarro S; Pinheiro M; Pinto C; Henrique R; Teixeira MR
J Mol Diagn; 2014 May; 16(3):324-34. PubMed ID: 24607278
[TBL] [Abstract][Full Text] [Related]
11. Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants.
Sahu S; Sullivan TL; Mitrophanov AY; Galloux M; Nousome D; Southon E; Caylor D; Mishra AP; Evans CN; Clapp ME; Burkett S; Malys T; Chari R; Biswas K; Sharan SK
PLoS Genet; 2023 Sep; 19(9):e1010940. PubMed ID: 37713444
[TBL] [Abstract][Full Text] [Related]
12. DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment.
Toland AE; Andreassen PR
J Med Genet; 2017 Nov; 54(11):721-731. PubMed ID: 28866612
[TBL] [Abstract][Full Text] [Related]
13. Effect of the overexpression of BRCA2 unclassified missense variants on spontaneous homologous recombination in human cells.
Balia C; Galli A; Caligo MA
Breast Cancer Res Treat; 2011 Oct; 129(3):1001-9. PubMed ID: 21671020
[TBL] [Abstract][Full Text] [Related]
14. Effect of the expression of BRCA2 on spontaneous homologous recombination and DNA damage-induced nuclear foci in Saccharomyces cerevisiae.
Spugnesi L; Balia C; Collavoli A; Falaschi E; Quercioli V; Caligo MA; Galli A
Mutagenesis; 2013 Mar; 28(2):187-95. PubMed ID: 23328489
[TBL] [Abstract][Full Text] [Related]
15. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
[TBL] [Abstract][Full Text] [Related]
16. Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.
Machackova E; Claes K; Mikova M; Házová J; Sťahlová EH; Vasickova P; Trbusek M; Navrátilová M; Svoboda M; Foretová L
Klin Onkol; 2019; 32(Supplementum2):51-71. PubMed ID: 31409081
[TBL] [Abstract][Full Text] [Related]
17. Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2.
Kuznetsov SG; Liu P; Sharan SK
Nat Med; 2008 Aug; 14(8):875-81. PubMed ID: 18607349
[TBL] [Abstract][Full Text] [Related]
18. Functional evaluation of variants of unknown significance in the BRCA2 gene identified in genetic testing.
Heczkova M; Machackova E; Macinga P; Gallmeier E; Cahova M; Spicak J; Jirsa M; Foretova L; Hucl T
Cancer Biol Ther; 2019; 20(5):633-641. PubMed ID: 30638113
[TBL] [Abstract][Full Text] [Related]
19. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
20. Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant.
Li L; Biswas K; Habib LA; Kuznetsov SG; Hamel N; Kirchhoff T; Wong N; Armel S; Chong G; Narod SA; Claes K; Offit K; Robson ME; Stauffer S; Sharan SK; Foulkes WD
Hum Mutat; 2009 Nov; 30(11):1543-50. PubMed ID: 19795481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
